Blood Pressure Drug Disappoints in Slowing Parkinson’s

Blood Pressure Drug Disappoints in Slowing Parkinson’s
PHILADELPHIA — Despite previous research suggesting the calcium channel blocker isradipine (DynaCirc, Novartis) may slow progression of Parkinson's disease (PD), results of a new phase 3 ... read more
Source: Bing NewsPublished on 2019-05-02